KHINDIVI is the first and only FDA-approved hydrocortisone oral solution• Commercial launch expected the week of June 2nd• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocort ...

Eton Pharmaceuticals, Inc (“Eton” or“the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the U.S.

KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2 nd • ...

Glaucoma is a serious eye condition that can affect both dogs and cats, leading to increased pressure within the eye ...

Recruitment was stopped 6 months prematurely because of coronavirus disease 2019 (COVID-19)-related hospital ... pheochromocytoma, and Cushing syndrome), long-term corticosteroid therapy, renal ...

Obesity is on the rise in Singapore, with recent studies revealing a worrying trend. The 2021/2022 National Population Health ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...